Indian Cassia Seed (Cinnamomum tamala)

Indian Cassia Seed (Cinnamomum tamala) contains cinnamaldehyde and polyphenolic compounds that drive its primary biological activities. These bioactives inhibit tyrosinase enzyme activity and exhibit antioxidant effects, positioning this seed as a candidate ingredient in skin health and immune-related research.

Origin & History

Cinnamomum tamala, commonly known as Indian bay leaf or tejapatra, is a tree species native to the Himalayan region whose leaves have been used as a culinary spice and medicinal ingredient since ancient times. The plant material is typically harvested as dried leaves containing volatile essential oils extracted through steam distillation or solvent extraction methods, with chemical composition varying by plant part and geographic origin.

Historical & Cultural Context

C. tamala (tejapatra) has been used in traditional Ayurvedic medicine for centuries, particularly in the Himalayan region, with applications as an anti-flatulent, diuretic, and carminative agent. The leaves have been employed as a culinary spice throughout the world since ancient times, recognized for their anti-oxidative potential.

Health Benefits

• Skin health support through tyrosinase inhibition (demonstrated in vitro) for potential melanin production control
• Immunomodulatory effects showing activity against murine lymphocytes (laboratory studies only)
• Antioxidant properties from cinnamaldehyde and polyphenol content (in vitro evidence)
• Traditional digestive support as carminative and anti-flatulent agent (historical use, no clinical trials)
• Potential cardiovascular support from bioactive compounds including coumarin and trans-cinnamic acid (preliminary laboratory evidence)

How It Works

Cinnamaldehyde, the principal bioactive in Cinnamomum tamala seed, inhibits tyrosinase by competing at the enzyme's copper-containing active site, thereby reducing the oxidative conversion of L-tyrosine to melanin precursors. Polyphenolic constituents scavenge reactive oxygen species (ROS) by donating hydrogen atoms to free radicals, reducing lipid peroxidation chain reactions. Immunomodulatory activity appears to involve modulation of murine lymphocyte proliferation, though the precise receptor-level pathways—whether through toll-like receptors or cytokine signaling cascades—have not yet been fully characterized in published literature.

Scientific Research

The available research consists primarily of in vitro studies and phytochemical reviews rather than human clinical trials. No randomized controlled trials (RCTs), meta-analyses, or PubMed PMIDs documenting clinical efficacy in human subjects were found in the provided research dossier.

Clinical Summary

Current evidence for Indian Cassia Seed is derived exclusively from in vitro cell-based assays and murine laboratory studies; no published human clinical trials exist for this specific ingredient as of the available data. Tyrosinase inhibition has been demonstrated in cell-free enzymatic assays, with studies reporting IC50 values for cinnamaldehyde-containing extracts, though these have not been translated to controlled human skin studies. Immunomodulatory findings are limited to murine lymphocyte proliferation models, which do not reliably predict human immune responses. The overall evidence base must be characterized as preliminary, and efficacy claims for human applications remain unsubstantiated without randomized controlled trial data.

Nutritional Profile

Indian Cassia Seed (Cinnamomum tamala) nutritional data is limited in peer-reviewed literature, but the following constituents are documented: Bioactive volatile compounds include cinnamaldehyde (primary phenylpropanoid, estimated 40-60% of essential oil fraction), eugenol (5-15% of essential oil), linalool, and beta-caryophyllene. Polyphenolic content includes tannins (condensed and hydrolyzable forms, approximately 2-5% dry weight basis based on related Cinnamomum species), flavonoids including quercetin and kaempferol derivatives, and catechins. Fixed oil content is approximately 1-3% of seed dry weight, composed primarily of oleic, linoleic, and lauric fatty acids. Crude fiber content is estimated at 8-15% dry weight, consistent with other Cinnamomum seed matrices. Protein content is modest, approximately 3-6% dry weight. Mineral constituents documented in related Cinnamomum seeds include calcium (100-200 mg/100g estimated), iron (2-5 mg/100g estimated), and potassium. Starch and carbohydrate fractions constitute approximately 40-55% dry weight. Bioavailability note: cinnamaldehyde undergoes rapid first-pass hepatic metabolism to cinnamic acid; polyphenol bioavailability is matrix-dependent and likely moderate. Data is primarily extrapolated from Cinnamomum zeylanicum and C. cassia seed studies; species-specific quantitative nutritional analyses for C. tamala seeds remain sparse in published literature.

Preparation & Dosage

No clinically studied dosage ranges for human use, standardized extract concentrations, or dosing protocols are documented in the available research. Traditional uses mention anti-flatulent and diuretic properties but without evidence-based dosage recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, Black Pepper, Cinnamon bark, Cardamom

Safety & Interactions

No established human safety profile exists for isolated Indian Cassia Seed extract as a supplement, as clinical safety trials have not been conducted. Cinnamaldehyde, the primary bioactive, is a known contact sensitizer and may cause allergic skin reactions or oral mucosal irritation at concentrated doses. Individuals taking anticoagulant medications such as warfarin should exercise caution, as cinnamon-related species have demonstrated platelet aggregation inhibition and potential CYP450 enzyme interactions in preclinical studies. Pregnant or breastfeeding individuals should avoid supplemental use due to a complete absence of safety data in these populations.